Thyroid gland papillary carcinoma
MONDO:0005075A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries. Diagnostic procedures include thyroid ultrasound and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance.
Also known as: papillary cancer of the thyroid, papillary cancer of the thyroid gland, papillary cancer of thyroid, papillary cancer of thyroid gland, papillary carcinoma of the thyroid, papillary carcinoma of the thyroid gland, papillary carcinoma of thyroid, papillary carcinoma of thyroid gland
2814 clinical trials for this condition and its sub-types, 59 tagged with Thyroid gland papillary carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Thyroid gland papillary carcinoma
-
Thyroid cancer, nonmedullary, 1 1 trial
-
New drug hope for rare throat and thyroid cancers
Disease control Not yet recruitingThis study tests a drug called sacituzumab tirumotecan in people with two rare cancers: adenoid cystic carcinoma (a type of salivary gland cancer) and papillary thyroid carcinoma that have returned or spread. About 68 participants will receive the drug through an IV twice a month…
Phase 2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Thyroid cancer surgery debate: to dissect or not to dissect neck nodes?
Disease control Not yet recruitingThis study looks at people with papillary thyroid cancer tumors 2 to 4 cm who are having thyroid surgery. Half will also have nearby neck lymph nodes removed, and half will not. The goal is to see if removing these nodes lowers the chance of cancer coming back or persisting, and …
Sponsor: Leonardo Rossi • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Blue dye could make thyroid cancer surgery safer and more precise
Disease control Not yet recruitingThis study tests whether injecting a blue dye called mitoxantrone hydrochloride into the thyroid during robotic surgery helps surgeons see and remove cancer-affected lymph nodes while avoiding the parathyroid glands. 114 people with papillary thyroid cancer will be randomly assig…
Phase 4 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New thyroid test aims to cut unnecessary surgeries
Diagnosis Not yet recruitingThis study looks at whether a genetic test called Thyroid GuidePx® can help doctors and patients with papillary thyroid cancer make better treatment choices. About 85 adults with early-stage thyroid cancer will take the test before surgery. Researchers will see if the test result…
Sponsor: University of Calgary • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
AI assistant aims to ease thyroid cancer anxiety before surgery
Symptom relief Not yet recruitingThis study tests whether an online educational tool called THRIVE, powered by artificial intelligence, can help people newly diagnosed with thyroid cancer feel less anxious and more confident about their treatment choices. Participants use the tool on their own device before meet…
Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New online tool aims to ease cancer worry in young adults
Symptom relief Not yet recruitingThis pilot trial tests whether adding emotional support to a cancer information website helps young adults (ages 20-39) with thyroid, melanoma, or testicular cancer feel less worried and distressed. 142 participants will either get general cancer info or the same info plus person…
Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a pamphlet ease the anxiety of choosing thyroid cancer treatment?
Symptom relief Not yet recruitingLow-risk thyroid cancer grows very slowly and has a 99% survival rate, but choosing among three treatment options can be stressful. This study gives patients a decision aid pamphlet right after diagnosis, before they see a surgeon. The pamphlet explains the options and lists ques…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Mapping how thyroid tumors spread and what surgery leaves behind
Knowledge-focused Not yet recruitingResearchers at Sohag University Hospitals are reviewing the medical records of 30 people treated for papillary thyroid cancer, the most common type of thyroid cancer. The study examines how far tumors extended beyond the thyroid gland and which complications appeared soon after s…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Urine test could revolutionize thyroid cancer Follow-Up
Knowledge-focused Not yet recruitingThis study aims to improve how doctors predict and monitor thyroid cancer by combining genetic testing of tumors with protein analysis from urine samples. Researchers will follow 100 newly diagnosed thyroid cancer patients to see if these markers can detect early signs of recurre…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
AI reads ultrasounds to spot hidden thyroid cancer spread
Knowledge-focused Not yet recruitingThis study aims to develop an AI model that analyzes neck ultrasound images and reports to predict whether thyroid cancer has spread to nearby lymph nodes. Researchers will compare the AI's predictions with actual surgical results from 3,200 patients. If successful, this tool cou…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC